|
?:authorAffiliation
|
-
[\'Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, REPROGRAM Telemedicine Study Group, Sydney, NSW, Australia.\', \'Neurovascular Imaging Laboratory & NSW Brain Clot Bank, Department of Neurology, Liverpool Hospital and South Western Sydney Local Health District, Ingham Institute for Applied Medical Research, The University of New South Wales, Sydney, NSW, Australia.\', \'The University of New South Wales (UNSW) Medicine Sydney, South West Sydney Clinical School, Sydney, NSW, Australia.\', \'The University of the West Indies, St. Augustine, Trinidad and Tobago.\', \'Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland.\', \'Department of Medicine, St. Michael\'s Hospital, University of Toronto, Toronto, ON, Canada.\', \'Alberta Health Services and Project PoSSUM, University of Alberta, Edmonton, AB, Canada.\', \'Penn Medicine Lancaster General Hospital and Project PoSSUM, Lancaster, PA, United States.\', \'Farr Institute of Health Informatics, University College London (UCL) & NHS Foundation Trust, Birmingham, United Kingdom.\', \'Polish Mother\'s Memorial Hospital Research Institute (PMMHRI) in Lodz, Cardiovascular Research Centre, University of Zielona Gora, Zielona Gora, Poland.\', \'Department of Hypertension, Medical University of Lodz, Łódź, Poland.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}